Research ArticleErratum

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy

Cristina Teixidó, Niki Karachaliou, Maria González-Cao, Daniela Morales-Espinosa and Rafael Rosell
Cancer Biology & Medicine September 2015, 12 (3) 259; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0055

References

  1. 1.↵
    2. Teixidó C,
    3. Karachaliou N,
    4. González-Cao M,
    5. Morales-Espinosa D,
    6. Rosell R.
    Assays for predicting and monitoring responses to lung cancer immunotherapy. Cancer Biol Med 2015;12:87–95.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    2. Garon EB,
    3. Rizvi NA,
    4. Hui R,
    5. Leighl N,
    6. Balmanoukian AS,
    7. Eder JP, et al.
    Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 2015;372:2018–2028.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section